The main objective of this study is to establish potential neuromorphometric differences which might act as markers of genetic risk for bipolar disorder and therefore serve as endophenotypes for discovery of genes that contribute to bipolar disorder. Magnetic resonance imaging (MRI) was used to assess structural brain volumes of 49 subjects. Volumetric analyses were first performed to test possible differences in the volume of brain structures between subjects with bipolar disorder type I (BPI) and control subjects in a new sample, based on regions previously reported in the literature as being either increased or decreased in size in bipolar patients. Subsequently, for those brain regions showing statistical difference between subjects with BPI and control subjects in our new sample, we tested whether unaffected first degree relatives (UFRs) of the BPI subjects also showed similar differences compared with controls. Four specific regions (right prefrontal, right middle prefrontal, right globus pallidus and left globus pallidus) met criteria for being possible endophenotypes for BPI in this sample.
Introduction
Bipolar affective disorder type I (BPI) is a lifelong and potentially devastating mood disorder characterized by one or more episodes of mania often alternating with periods of depression (American Psychiatric Association, 2013) . Although research studies have suggested that there is a significant genetic contribution to the risk of BPI, large-scale genetic studies of BPI have thus far had limited success in identifying the specific gene variants that explain the heightened genetic risk for bipolar disorder. The clinical complexity and the highly variable symptomatic presentation of BPI make the identification of these genes a challenging endeavor (Glahn et al., 2004) . Gottesman and Gould (2003) theorized that a promising approach for the study of the genetic components of mental disorders would be to first identify endophenotypes that are genetically correlated with the particular mental disorder. An endophenotype is a quantitative measure (Gottesman and Gould, 2003) that is altered in persons with the phenotype in comparison to healthy controls. Ideally, an endophenotype for BPI should also be altered in those who share genetic risk for a disease (i.e., first degree relatives of BPI patients; Glahn et al., 2007) . One can then identify the genes influencing these endophenotypes as a means of better understanding the genetic factors responsible for the phenotype of BPI. Structural brain characteristics have been suggested as one possible endophenotypic measure for BPI (Hariri and Weinberger, 2003; Glahn et al., 2007) . Anatomical brain volumes are quantitatively measurable, and recent research has suggested high heritability of volume in specific regions (Hariri and Weinberger, 2003; Glahn et al., 2007) . In addition, a number of previous imaging studies of bipolar disorder have suggested that there might be an alteration of brain structures associated with BPI. In the present article, we first review the literature to identify brain regions that have been shown to differ in size between subjects with BPI and controls. We then test each of these regions in a new study sample, Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/psychresns to see if we are able to replicate these differences in a sample of subjects with BPI and control subjects with no personal or family history of mental illness collected for genetic research studies of bipolar disorder. Next, for those regions showing statistical differences between BPI cases and control cases (subjects with no personal or family history of BPI), we test whether a group of first degree relatives (with no personal history of mood or psychotic disorders) of the BPI subjects also show differences in these brain regions when compared with the control sample.
Brain regions previously associated with BPI
In our review of the literature, we identified a number of brain regions that have been reported as differing in size between bipolar patients and unaffected controls. These regions of interest are summarized below and in Table 1 .
Prefrontal cortex
In the literature, there have been studies looking at the prefrontal cortex as a whole and in subsections. López-Larson et al. (2002) reported that bipolar patients had smaller left and right prefrontal gray matter volumes compared with controls. They also reported specific substructures of these cortices (left superior and middle prefrontal gray matter and right inferior and middle prefrontal gray matter volumes) differed in size between persons with bipolar disorder and control subjects. Matsuo et al. (2012) also found that subjects with BPI showed smaller right inferior frontal gyrus gray matter volumes when compared with control subjects, presumably referring to the right inferior prefrontal region. Sassi et al. (2004) used magnetic resonance imaging (MRI) to compare the volumes of the left, right, anterior, and posterior cingulate cortices between untreated bipolar mood disorder patients and healthy controls, and noted significantly reduced left anterior cingulate volumes in untreated subjects with bipolar disorder (BPD) compared with control subjects with no history of BPD.
Cingulate cortex
1.1.3. Orbitofrontal cortex Eker et al. (2014) reported smaller volumes of the left orbitofrontal cortex in patients with BPD compared with unrelated control subjects with no history of BPD, and found the same was true for healthy siblings of the bipolar patients compared with unrelated controls; they postulated that this difference may be a risk marker for BPD. Nery et al. (2009) conducted an anatomical MRI study where they examined orbitofrontal cortex gray matter volumes in subjects with BPD compared with control subjects. Although they did not identify any volumetric differences between subjects with and without BPD, they noted that orbitofrontal cortex gray matter volumes were inversely correlated with depressive symptom severity, suggesting that orbitofrontal cortex gray matter reductions could be associated with the depressive features of BPD.
Insula
Matsuo et al. (2012) found statistically significant reductions in volume of the left anterior insula grey matter with BPD subjects compared with controls.
1.1.5. Amygdala Strakowski et al. (1999) reported significantly larger amygdala size (bilaterally) in subjects with BPD compared with controls. Eker et al. (2014) reported smaller left orbitofrontal cortex in patients with BPD compared with unrelated control subjects, and found the same was true for healthy siblings of the bipolar patients compared with unrelated controls; they suggested that this difference could be a risk marker for BPD.
Recent meta-analyses have also suggested several brain regions which may differ between BPD subjects and controls. These include the following regions:
Lateral ventricles
In a meta-analysis by Kempton et al. (2008) , lateral ventricular enlargement was reported in subjects with BPD. This finding was also revealed in the meta-analysis of Arnone et al. (2009) , which found both left and right ventricles to be significantly enlarged in subjects with BPD compared with controls.
Whole brain volume reduction
A meta-analysis of MRI studies of bipolar disorder and schizophrenia by Arnone et al. (2009) found whole brain reductions in subjects with BPD compared with controls. Arnone et al. (2009) , in a meta-analysis, reported that subjects with BPD showed increases in size of the globus pallidus (bilaterally) compared with controls.
Globus pallidus

Goals of the current study
In this study, we used automated structural brain segmentation and quantification to investigate which, if any, of these 15 regions (Table 1) would meet some of the key criteria for being an endophenotype for BPI in a new sample of subjects. Specifically, we hypothesized that each of these regions would show volumetric differences between BPI subjects and unrelated healthy controls. For any region that met this criterion in our sample, we then proceeded to test whether unaffected first degree relatives (UFR) of BPI subjects would also show similar differences in volume compared with unrelated healthy controls. Brain structures that satisfied both of these criteria in the present study would satisfy key criteria needed to define an endophenotype for bipolar disorder: differences in a quantifiable measure between BPI cases and controls, and similar differences between unaffected relatives of BPI cases and controls. In addition to testing these specific regions, we also performed post hoc analyses on a large number of additional brain regions, bilaterally, to see if we could identify any novel regions of potential interest as endophenotypes for BPI.
Methods
Subjects and diagnostic assessments
Demographic variables for the subjects in this study are shown in Table 2 . All subjects in the current study were recruited in San Antonio, Texas. BPI patients (7 males, 11 females) and first degree relatives of BPI subjects who had no history of mood disorder (UFRs) (5 males, 7 females) were recruited as part of the study "Genetics of Bipolar Disorder in Latino Populations" (R01MH069856). A bilingual psychiatrist completed a semi-structured interview for all affected subjects (BPI cases and bipolar spectrum phenotypes) as well as all possible first degree relatives in each pedigree using the Diagnostic Interview for Genetic Studies (DIGS; Nurnberger et al., 1994) . Interviewing psychiatrists were blind to any familial relationship between subjects. A Family Interview for Genetic Studies (FIGS; Maxwell, 1992) was also completed for each family, which gave additional clinical information regarding all subjects in the family. Clinical data from these interviews, along with medical and psychiatric records, were used by a best estimate team consisting of psychologists and psychiatrists to assign final consensus diagnoses using DSM-IV criteria (Gonzalez et al., 2013) as well as diagnoses of history of manic, depressed, and psychotic episodes or syndromes. All BPI subjects used in these analyses met full DSM-IV criteria for BPI, by consensus best estimate diagnosis. Since the subjects were initially diagnosed, the DSM-5 has been published. All of our subjects diagnosed as BPI by DSM-IV criteria also meet the criteria for BPI as defined by the DSM-5.
First degree relatives selected for analysis in the present study had no history of psychosis, and no history of full depressive or manic episodes or syndromes. In addition they, as well as the BPI subjects, had no current alcohol/substance abuse or dependence. Of the first degree relatives, seven had no history of any Axis I disorder, two had a history of specific phobias only, and the remaining three had only a history of bereavement (not meeting criteria for depression). All first degree relatives included in this analysis had at least one first degree relative (sibling, parent, or child) that met criteria for BPI by consensus best estimate diagnoses using the procedures mentioned above.
Control (C) subjects (7 males, 11 females) were recruited from the local community, also in San Antonio, Texas, and had no DSM-IV axis I disorders, as determined by the SCID-IV non-patient version interview (SCID-NP). Moreover, they had no current medical problems, and no history of psychiatric disorders among first degree relatives.
Imaging data acquisition
T1-weighted MRI brain scans were acquired on a 3T Siemens (Erlangen, Germany) Trio scanner with an eight-channel head coil in the Research Imaging Institute, University of Texas Health Science Center at San Antonio, using the following scan parameters: isotropic anatomic images (800 μm), echo time ¼ 2.83 ms, repetition time ¼ 2200 ms, flip angle ¼13°.
MRI image pre-processing
All T1-weighted MRI scans were visually inspected to rule out any gross artifacts. Freesurfer software (http://surfer.nmr.mgh.harvard.edu/) Version 5.3.0 (Fischl, 2012) was used to segment and parcellate the cerebral cortex into 34 regions of interest using a pre-defined atlas (Desikan et al., 2006) . Anatomical volumes were exported for statistical analyses. Components of the prefrontal cortex were analyzed individually and also as a region to provide information about volume differences in these specific areas. Prefrontal cortex volumes were calculated by adding the superior frontal, rostral middle frontal, caudal middle frontal, pars opercularis, pars triangularis, and pars orbitalis Freesurfer volumes. In post hoc analyses, we also assessed the dorsolateral prefrontal cortex, defined by combining superior frontal, rostral middle frontal and caudal middle frontal volumes, on both the left and right sides of the brain.
Image and statistical analyses
All analyses were conducted using SAS V.9.3. The first set of analyses performed involved attempts to replicate the 15 specific brain regions (Table 1) that had previously been shown to significantly differ between subjects with BPI and control subjects. A linear regression analysis with age and gender corrections was conducted for control vs. BPI subjects and also for controls vs. UFR subjects on those specific brain regions of interest (Table 3) . As each of these expected differences was an a priori hypothesis (previously shown to be significant), we set a threshold for significant replication at p o 0.05. For the given sample size in these analyses, using measures of the globus pallidus as an example, we had moderate power (4 50%) to detect differences in regions of interest between groups at an alpha p value of 0.05 or less.
Since each of the sections that showed significant differences between BPI cases and controls (p o0.05) was then also tested between unaffected first degree relatives and the same control samples, we required an adjustment for the fact that two comparisons were done using the same control group, and statistical adjustment (Bonferroni) thus required a p value less than 0.025 (0.05/2) to meet criteria for significance. Table 3 presents p values without Bonferroni correction (these are nominal p values). Those passing a Bonferroni correction for significance are highlighted in Table 3 with the symbol ǂ.
In post hoc analyses a linear regression with age and gender corrections was conducted for C vs. BPI subjects and also for C vs. UFR subjects on a number of additional brain regions that were not in our list of hypothesized regions. These regions included structures on the opposite side of hypothesized regions, left and right total cortical volume, and a number of additional substructures of hypothesized regions on both left and right sides of the brain (Table 4) . As we were not testing specific a priori hypotheses here, the p values reported in Table 4 are nominal (uncorrected). In order for any of these to pass the threshold for significance, considering multiple testing, at the strictest level, we suggest a statistical adjustment which corrects for 13 independent regions (all listed sections except for the subsections of the prefrontal cortices) and two tests (BPI vs. controls and UFR vs. controls), requiring a Bonferroni corrected p value of 0.05/26 ¼0.0019 to be considered significant. Continuous data are summarized for each region of interest studied, for the C, UHR, and BPI groups, using means and standard deviations in Table 5 .
Results
Results of the 15 regions (all hypothesized to be different in size between BPIs and controls based on literature review) tested are summarized in Table 3 . Seven of these regions met our a priori criterion (po 0.05) for a significant difference in size between BPI subjects and controls. After correction for multiple testing, regions that still showed significant differences between BPI and control subjects (at p o0.025) included the right prefrontal cortex (and the right middle prefrontal and right inferior prefrontal subsections) and the right and left globus pallidum. The left prefrontal, left superior prefrontal, left middle prefrontal cortex and right amygdala showed non-significant (after Bonferroni correction) trends (p ¼0.0263, p ¼0.069, p ¼0.041 and p ¼0.073, respectively) toward differences in size between BPI subjects and controls. When total cortical volume is included as an additional co-variable (in addition to gender and age), regions showing significant differences (po 0.025) between cases and controls are similar: right prefrontal (p¼ 0.0004), right middle prefrontal (p ¼0.002), right inferior prefrontal (p ¼0.028), left prefrontal region (p ¼0.016), and both left and right globus pallidus (p¼ 0.024 and p ¼0.017), respectively.
As shown in Table 3 , four (right prefrontal, right middle prefrontal, right and left globus pallidus) of the five regions which showed significant size differences (after Bonferroni correction) between BPI and C subjects also showed Bonferroni-corrected significant size differences (p o0.025) between the UFR and control samples. When total cortical volume is added as an additional co-variable (in addition to gender and age), only the left globus pallidus is significant at the level of po 0.05 in both BPI subjects vs. controls (p¼ 0.024) and UFR subjects vs. controls (p ¼0.015).
In post hoc analyses (Table 4) , we examined a number of additional brain regions that were not in our list of hypothesized regions. This included structures on the opposite side of hypothesized regions (left prefrontal, right orbitofrontal, right anterior cingulate, right superior frontal), separate analyses of left and right total cortical volume, and a number of additional structures and substructures on both the left and right sides of the brain (dorsolateral prefrontal cortex, rostral middle frontal, caudal middle frontal, insula, temporal gyri, temporal poles, pars opercularis, pars triangularis, pars orbitalis). Of note, this identified the following additional structures which met nominal criteria (differences between BPI vs. control subjects and UFR vs. control subjects, both at po 0.05): left and right dorsolateral prefrontal cortex, right superior prefrontal cortex, and left and right rostral middle prefrontal cortex. After Bonferroni correction for multiple testing (see Section 2), only the following regions showed significant (p o0.0019) differences between UFR vs. control subjects in these post hoc analyses: right and left prefrontal cortex, right and left dorsolateral prefrontal cortex, left rostral middle prefrontal, right superior prefrontal, and right insula. When total cortical volume is included as a co-variable (in addition to gender), no additional regions in the post hoc analyses are significantly different between cases and controls, beyond those listed above (right and left prefrontal regions and globus pallidum differ between BPI vs control subjects, and left globus pallidus differs between UFR and control subjects).
Discussion
The current study attempted to identify potential brain structures, defined by MRI, which would meet the criteria for being endophenotypes for BPI. We first tested a number of structures that previous studies had identified as being altered in size in BPI compared with control subjects, confirming that the right prefrontal cortex and both the right and left pallidal structures differed in size between BPI subjects and controls. The left prefrontal cortex also showed a nearly significant difference (p ¼0.0263) in size between BPI cases and controls. In addition, all of these structures showed differences in size between UFR subjects and controls. For each of these structures, the differences in size between BPI subjects and controls (as well as between UFR subjects and controls) was in the same direction as predicted from the literature, with the exception of the left and right globus pallidum (which were both decreased in size for BPI and UFR subjects compared with controls).
Prefrontal regions
Clearly, the bilateral prefrontal cortex represents a promising area for future research attempting to identify endophenotypes for BPI. The right prefrontal cortex met our criteria for being a potential endophenotype. Bilaterally, the dorsolateral prefrontal cortices, superior and middle frontal cortices, as defined in the current study, all showed nominal evidence of being reduced in size for both BPI subjects and UFR subjects compared with controls. This suggests that a decrease in these structures is not just related to having a diagnosis of BPI disorder but is also a marker for genetic risk of BPI (i.e., unaffected relatives who are at genetic risk for BPI but have not presented any manic or depressed episodes also show decreases in these structures). Where to draw the line regarding where the "prefrontal" structures are altered in those at genetic risk for BPI is unclear, as, based on data from our study, one could find a number of the substructures meeting criteria for being endophenotypes. We report on all of these (including dorsolateral prefrontal cortex) in this article so that these data will be available for researchers interested in which portions of the frontal cortices may be pertinent as endophenotypes for BPI.
Our findings indicating that these prefrontal regions are Values in cubic millimeters (mm 3 ). UFR, unaffected first degree relatives. LDLPFC, left dorsolateral prefrontal cortex. RDLPFC, right dorsolateral prefrontal cortex.
potential structural endophenotypes for bipolar disorder are consistent with the literature, which has shown that cognitive functions that rely on prefrontal cortical activity, such as working memory and executive function, are altered in persons with bipolar disorder compared with controls. Of course, it is difficult to exactly map neurocognitive functions onto brain anatomy, as they typically involve several regions of the brain. Functional imaging studies have shown that there are specific activation abnormalities in bipolar patients in both dorsolateral prefrontal cortices while they perform specific tasks (Glahn et al., 2010) . Functional MRI research has also suggested that decreased activity in the dorsolateral prefrontal cortex regions is a feature of both mania and depression in bipolar patients in comparison to controls (PomarolClotet et al., 2014) . Lee et al. (2014) have also shown decreased activation in the dorsolateral prefrontal cortex in pediatric bipolar cases compared with controls. Our findings are also consistent with a recent study by Fears et al. (2014) which showed that characteristics of dorsolateral prefrontal cortex and inferior frontal cortex regions are both heritable and associated with bipolar disorder in extended pedigrees.
As to whether the prefrontal cortices (bilaterally) or specific subregions within these areas are genetically correlated with bipolar disorder, our results suggest that several ways of parsing this region of the brain will meet the necessary criteria for use as endophenotypes. Potentials areas include left and right prefrontal cortex (as defined in Section 2), right or left dorsolateral prefrontal cortex (as defined in Section 2), and a number of subregions (left and right rostral middle prefrontal, right inferior prefrontal).
Globus pallidus and amygdala
Previous research has implicated the globus pallidus (bilaterally) as a region that is altered in size in bipolar subjects compared with controls (Strakowski et al., 1999) . Although our research found significant differences in globus pallidus size between both BPI and UFR subjects compared with controls, the differences in size were in the opposite direction from the findings by Strakowski et al. (Table 1 ). In the study by Strakowski et al., the bipolar patients had an average duration of illness of 6 years, in comparison to our subjects, who on average had a duration of illness of over 14 years ( Table 2 ). The differences in our findings may therefore reflect changes in the globus pallidus which occur over time in the course of bipolar disorder. Additionally, clinical differences such as medications, comorbidities and number of episodes of depression and mania may account for the differences observed in our study and the study of Strakowski et al. Interestingly, a more recent study by Womer et al. (2014) showed that non-psychotic bipolar patients showed reduced globus pallidus size compared with controls, and the investigators suggested that reduced globus pallidus size might relate to depression (a prominent component of bipolar disorder). Medications, particularly first generation antipsychotics, may affect globus pallidus size over time, but such effects are thought to cause increases in size (Boonstra et al., 2011) . The exact roles of the globus pallidus in emotion and cognition are not fully understood, but Womer et al. (2014) , based on their research on lesions in this area of the brain, suggested that the globus pallidum may have roles in motivation, sensitivity to reward effects, and depressive symptoms. In terms of the amygdala, we did not find support at the level of significance defined a priori, for an association with BPI, but we did show the right amygdala size to be approaching statistically significant differences in BPI compared to control subjects, and we also found the left amygdala to be significantly different in size in UFR subjects compared with controls. Interestingly, we also found the differences in amygdala size to be in the opposite direction to that reported on by Strakowski et al. Both studies suggest that globus pallidus and amygdala structures are potentially of interest as phenotypes related to bipolar disorder, but our findings suggest that the prefrontal cortex and several of its substructures are more likely to serve as consistent endophenotypes for BPI.
Total cortex and ventricle sizes
Our data did not support findings from previous meta-analyses which showed total cortex size and ventricle sizes differed between bipolar subjects and controls, in the sense that we did not find significant (p o0.05) evidence in our sample (Table 3) . As the previous findings that generated this hypothesis (Arnone et al., 2009 ) derived from meta-analyses combining large numbers of samples, it is possible that the small sample size of the current study was not well suited to capture such differences. Interestingly, when total cortical volume was included as a co-variate in our linear regression analyses, differences between BPI and control subjects still emerged in the right and left prefrontal regions and the right and left globus pallidum, but only the left globus pallidus (out of these regions) was also statistically significant between UFR and control subjects. Thus, if total cortical volume is included as a co-variable in our population-based studies, the left globus pallidum may be the best candidate to follow as an endophenotype.
Markers for disease state versus markers for genetic risk
Although the thrust of the current analyses was to test hypotheses regarding which brain structures are suitable for use as endophenotypes for BPI, it is useful to look at which of these traits might serve as markers of genetic risk for disease and which might serve as markers of the disease state itself. The following brain structures all meet nominal criteria (p o0.05) in our sample as differing in BPI subjects compared with controls, thus serving as potential markers of disease state for BPI: the right prefrontal cortex and its subsections (right middle prefrontal, right inferior prefrontal, right dorsolateral prefrontal, right rostral middle frontal), left prefrontal cortex and its subsections (left superior prefrontal, left middle prefrontal, left dorsolateral prefrontal, left rostral middle frontal), right and left globus pallidum, and (approaching significance) right amygdala. By contrast, our data support the following structures as meeting nominal criteria (p o0.05) for differing between UFR and control subjects, thus qualifying as potential markers of genetic risk for BPI: the right and left prefrontal cortex and the subsections listed above, left and right globus pallidum, left and right orbitofrontal cortex, left and right insular cortex, left amygdala, right middle temporal gyrus, and total cortex (and its subsections, right and left cortex). Longitudinal studies would be necessary to further test how these different regions may be used as markers of genetic risk and disease state and progression.
Limitations, future research and concluding remarks
One limitation of the current study is the small sample size. The sample size had moderate power (50-60%) to detect statistically significant differences in the identified regions of interest. Future studies with a larger sample would be useful in order to confirm the present results, as well as to determine if some additional regions which were below our threshold of significance, might be potential endophenotypes as well. Longitudinal studies of persons with BPI as well as persons at risk for BPI would also be of use to determine how these anatomical differences might change over time. Longitudinal studies of patients with BPI would be useful from onset through progression of illness to better understand how episodes, psychiatric comorbidities, and pharmacologic and psychological therapies might moderate changes in these structures over time. Finally, more detailed, pedigree-based studies would be useful to determine how these brain regions co-segregate with BPI in multiplex families and to identify the specific genes contributing to these endophenotypes (especially those in both left and right prefrontal cortex regions) and therefore, ultimately, to the pathophysiology of bipolar disorder. Our data support that a significant amount of the genetically controlled biological activity which plays a role in bipolar disorder does so through prefrontal structures bi-laterally. As these are brain structures also known to be involved in the psychopathology of schizophrenia, it will be an important area of future research to better distinguish both the genetic and pathophysiologic overlap and differences between subjects with bipolar disorder and schizophrenia.
Given the paucity of bipolar neuroimaging research that has been conducted in subjects of Latino ancestry, it is interesting to note that the current sample involved all Latino subjects, primarily of Mexican ancestry, living in South Texas. Given the small size of the sample and the fact that it derived from one geographical region, extrapolation to the entire Latino population should be done with caution. Given that the literature has not found significant differences in the epidemiology or characteristics of bipolar disorder between Hispanic and non-Hispanic populations (Burnam et al., 1987) , we have no reason to suspect a priori that the biological endophenotypes for bipolar disorder will be significantly different across populations. Our data in general support this conclusion, as at least seven of the hypothesized regions (from studies conducted in largely non-Latino populations) were confirmed in the present study. The one other published study of which we are aware, conducted in Latino populations from Colombia and Costa Rica (Fears et al., 2014) , found similar results to our current study, with regard to dorsolateral prefrontal cortex and inferior prefrontal cortex regions being strong candidates as endophenotypes for bipolar disorder. Clearly, additional research in the Latino population is needed to make the current results more generalizable to Latinos from other regions of the world.
Collectively, this research demonstrates an important, but often understudied piece of the bipolar disorder puzzle. Unaffected family members show significantly lower total cortical volume, as well as lower volumes in a number of network regions, than healthy controls. Many of these differences in structure are also seen in BPI patients, but there are also some differences between the BPI patients and the unaffected relatives. To us, this highlights the importance of longitudinal studies; it may be the case that as BPI progresses, and potentially as a result of treatment, some of these brain regions remain altered in size while others normalize or change in opposite directions from those in the family members who do not develop BPI. Indeed, it may be the case that additional factors not tested here (environmental factors, treatment, or comorbidities) influence the time course of how markers of BPI genetic risk develop and alter over time.
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